ClinicalTrialsFinder

Advanced HR - Positive, HER2 - Negative Breast Cancer Clinical Trials in Shanghai

1 recruitingShanghai, China

Showing 1–1 of 1 trials

Recruiting
Not Applicable

A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer

Advanced HR - Positive, HER2 - Negative Breast CancerResistant to (Neo)Adjuvant Endocrine Therapy
Fudan University36 enrolled1 locationNCT06856200